Filing Details
- Accession Number:
- 0001209191-19-043398
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-26 17:28:21
- Reporting Period:
- 2019-06-13
- Accepted Time:
- 2019-07-26 17:28:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-06-13 | 65 | $6.42 | 158,012 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-14 | 65 | $6.37 | 158,120 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-17 | 65 | $6.32 | 158,163 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-18 | 65 | $6.35 | 158,193 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-19 | 65 | $6.34 | 158,213 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-20 | 65 | $6.32 | 158,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-21 | 65 | $6.33 | 158,346 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-24 | 65 | $6.53 | 158,402 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-25 | 65 | $6.55 | 158,427 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-26 | 65 | $6.53 | 158,499 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-27 | 65 | $6.47 | 158,575 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-28 | 65 | $6.49 | 158,624 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-01 | 65 | $6.52 | 158,772 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-02 | 65 | $6.49 | 158,837 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-03 | 65 | $6.45 | 158,902 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-05 | 65 | $6.48 | 158,967 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-08 | 65 | $6.36 | 159,032 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-09 | 65 | $6.14 | 159,097 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-10 | 65 | $6.06 | 159,162 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-11 | 65 | $5.93 | 159,227 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-12 | 65 | $6.01 | 159,292 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-15 | 65 | $5.84 | 159,357 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-16 | 65 | $5.87 | 159,422 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-17 | 65 | $5.84 | 159,487 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-18 | 65 | $5.83 | 159,542 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-19 | 65 | $5.69 | 159,607 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-22 | 65 | $5.75 | 159,672 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-24 | 65 | $5.92 | 159,737 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.